"Attention of the Holders of Securities in Physical Mode is invited to Circular No. SEBI/HO/MIRSD/PoD-1/P/CIR/2023/181 dated November 17, 2023 issued by SEBI."
Home
About Us
Company Profile
Corporate ETHOS
Mission
Vision
Board of Directors and KMPs
Board Committees
Products
Speciality Chemicals
Skin Care Products
Hospital Care Products
Generics
Investors
Financial Information
Investor Information
Annual Reports
Shareholding Pattern
Corporate Governance
Policies
Other Data
Newsapaper Publication
Shareholders Meetings/Other Disclosures
Disclosure under Reg 46 of SEBI (LODR) Regulations 2015.
Media
News & Press Release
Contact Us
Q4
Outcome of Board Meeting held on May 28, 2024
Intimation Of Submission Of Application To BSE Limited For Reclassfication Of Promoters Of the Company
Compliances-39(3) (LODR) - Intimation towards Loss of Share Certificates
Announcement under Regulation 30 (LODR)- Updates on Acquisition
Compliances-39(3) (LODR) - Intimation towards Issue of Duplicate Share Certificate
Board Meeting outcome for Allotment of Equity Shares issued on Preferential; Basis for Consideration other than cash
Announcement under Regulation 30 (LODR)-Acquisition
Announcement under Regulation 30 (LODR)_Allotment
Announcement to regulation 30_Considering requests from members belonging to Promoters and Promoters Group seeking Reclassification of their shareholding to Public Category
Board Meeting Outcome for Declaration Of Quarterly Results For The Quarter And Nine Months Ended 31St December 2023
Announcement under Regulation 30 (LODR) - Updates on Acquisition
Intimation regarding issue of duplicate Share Certificate – Pursuant to Regulation 39 (3) of
Intimation of the Board Meeting to be held on 12th February 2024
Voting results along with Scrutiniser's report of the EGM
Proceedings of the 01st Extraordinary General Meeting (“EGM”) for the FY 2023-24
Compliances-Reg. 39 (3) - Details of Loss of Certificate - Duplicate Certificate
Revised intimation under Reg. 39 (3) - Details of Loss of Certificate - Duplicate Certificate
Corrigendum To The Notice Of 01St Extraordinary General Meeting Of The Company For The Financial Year 2023-2024
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Announcement under Regulation 30 (LODR)-Acquisition
Announcement under Regulation 30 of SEBI (LODR)- Adoption Of New Line(S) Of Business
Announcement under Regulation 30 (LODR)-Change in Management
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Announcement under Regulation 30 (LODR)-Preferential Issue
Announcement under Regulation 30 (LODR)-Allotment
Outcome of the Board Meeting under Regulation 30 of SEBI (Listing Obligations and Dislcosure Requirements) Regulations, 2015
Prior Intimation of Board Meeting_bse_signed
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Announcement Under Regulation 30 - Execution Of Shareholders Agreement
Outcome of the Board Meeting under Regulation 30 of SEBI (Listing Obligations and Dislcosure Requirements) Regulations, 2015
Prior Intimation of Board Meeting_bse_signed
Home
About Us
Company Profile
Corporate ETHOS
Mission
Vision
Products
Personal Care Ingredients
Generics Ingredients
Hospital Care Products
Sking Care Products
Investors
Financial Information
Board of Directors
Annual Reports
Listing Updates
Shareholding Pattern
Corporate Governance
Half Yearly Compliances
Media
News & Press Release
Corporate Announcement
Gallery
Contact Us